PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 137 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2014. The put-call ratio across all filers is 1.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $560,000 | -44.1% | 15,066 | +0.9% | 0.02% | -33.3% |
| Q3 2016 | $1,002,000 | +86.9% | 14,937 | -18.1% | 0.02% | +60.0% |
| Q1 2016 | $536,000 | +54.5% | 18,240 | +295.7% | 0.02% | +150.0% |
| Q3 2015 | $347,000 | -33.0% | 4,609 | +3.9% | 0.01% | -33.3% |
| Q2 2015 | $518,000 | +103.9% | 4,434 | +230.6% | 0.01% | +125.0% |
| Q4 2014 | $254,000 | -51.7% | 1,341 | -39.2% | 0.00% | -60.0% |
| Q3 2014 | $526,000 | +13.1% | 2,205 | -68.7% | 0.01% | +42.9% |
| Q2 2014 | $465,000 | -42.1% | 7,045 | -8.7% | 0.01% | -30.0% |
| Q1 2014 | $803,000 | – | 7,713 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 207,500 | $21,609,000 | 4.97% |
| WEATHERBIE CAPITAL, LLC | 250,296 | $26,066,000 | 2.47% |
| Redmile Group, LLC | 172,092 | $17,922,000 | 2.14% |
| Tekla Capital Management LLC | 185,820 | $19,351,000 | 1.93% |
| Iguana Healthcare Management, LLC | 35,000 | $3,645,000 | 1.68% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $592,210,000 | 1.62% |
| Atika Capital Management LLC | 11,350 | $1,182,000 | 1.01% |
| Eventide Asset Management | 44,900 | $4,676,000 | 0.73% |
| Ghost Tree Capital, LLC | 11,330 | $1,180,000 | 0.70% |
| BB BIOTECH AG | 117,991 | $12,288,000 | 0.63% |